ResMed Inc. Just Recorded A 15% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
It was overall a positive result, with revenues beating expectations by 2.1% to hit US$1.2b. ResMed reported statutory earnings per share (EPS) US$2.04, which was a notable 15% above what the analysts had forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. See our latest analysis for ResMed Taking into account the latest results, the most recent consensus for ResMed from 23 analysts is for revenues of US$5.03b in 2025. If met, it would imply a notable 9.6% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to leap 25% to US$8.13. Before this earnings report, the analysts had been forecasting revenues of US$4.98b and earnings per share (EPS) of US$7.67 in 2025.
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- Wall Street Analysts See ResMed (RMD) as a Buy: Should You Invest? [Yahoo! Finance]Yahoo! Finance
- ResMed's (NYSE:RMD) investors will be pleased with their strong 101% return over the last five years [Yahoo! Finance]Yahoo! Finance
- Here's Why Investors Should Buy ResMed (RMD) Stock Now [Yahoo! Finance]Yahoo! Finance
- ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy [Yahoo! Finance]Yahoo! Finance
- ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP TherapyGlobeNewswire
RMD
Earnings
- 4/25/24 - Beat
RMD
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/15/24 - Form 144
- RMD's page on the SEC website